Wed, Aug 27, 2014, 7:19 AM EDT - U.S. Markets open in 2 hrs 11 mins

Recent

% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

mikeadd 6 posts  |  Last Activity: Aug 22, 2014 1:25 PM Member since: Jun 10, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mikeadd@bellsouth.net by mikeadd Aug 22, 2014 1:25 PM Flag

    I'm buying more shares based on what seems logical after Barda news. I don't believe the US Department of Health would be investing time and money on a company that would likely not be able to continue the agreed-upon studies. Surely, the DoH did their due diligence before continuing with Cytori. I am disappointed that Cytori is not further along as a company than they currently are. In fact, it is almost unbelievable that this breakthrough technology is still sitting on the side tracks. I would also like to know how the cosmetic surgery companies that have bought Cytori products are doing financially and the status of their patients who were treated with Celution systems. To me, the BARDA agreement is the only real news; the rest is just smoke.

    Sentiment: Buy

  • mikeadd@bellsouth.net by mikeadd Aug 6, 2014 10:03 AM Flag

    Glad I had a limit order in just for occasions like this. although I am regretful that what appears to be transitory effects occurred in three patients (2 of which resolved completely; 1 in process of), if you trust the science, this is a blip IMO that will add to overall knowledge base of how stem cells work and their effect on entire body, including side or adverse effects. love these kneejerk reactions. buying more at this pps. good luck to all, or most anyway. ciao Mike A

  • mikeadd@bellsouth.net mikeadd Aug 5, 2014 9:57 AM Flag

    actually, now that I've woken up a bit more, going back 2 the original topic of discussion, I'm wondering whether there's precedent for licensing ownership over use of a body part, which I assume adipose stem cells would fall under. If so, which I don't agree with because it would prohibit competition and/or research, the licensing would include cytori's ADC use because CELUTION system still includes ADC even though there are other entities including, ie, hormones, etc.

    Sentiment: Buy

  • mikeadd@bellsouth.net mikeadd Aug 5, 2014 9:45 AM Flag

    thnk u

    Sentiment: Buy

  • mikeadd@bellsouth.net mikeadd Aug 4, 2014 1:17 PM Flag

    I don't quite understand your post WST. I thought Cytori holds numerous patents on adipose-tissue-derived stem cells, and it would seem that MSC's ". . . exclusive license over intellectual property" means that my understanding is incorrect or Cytori has found a way to circumvent MSC's license. How can any entity hold a "license" or any other financial instrument that gives it rights over others' intellectual property? TIA. Mike A

    Sentiment: Buy

  • mikeadd@bellsouth.net by mikeadd Aug 2, 2014 9:36 AM Flag

    I've been in and out of cytx for quite a few years now and am frankly astounded that it is not trading at a minimum of $50. I'm a reasonable person with a microbiology background that gives me enough knowledge to know that cytx science is sound and has been proven to be so; therefore, the only other variable in this is management. Frankly I just don't get it. This is cutting edge medicine. oh well, looks like "another" good opp 2 accumulate. Good luck fellas and keep the valium stocked up.

OPTR
12.780.00(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.